BeOne Medicines
ONC
#649
Rank
C$49.39 B
Marketcap
C$446.41
Share price
-2.56%
Change (1 day)
51.98%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): C$0.24 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are C$4.97 Billion. In 2024 the company made an earning of -C$0.79 Billion, an increase over its 2023 earnings that were of -C$1.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.24 B-131.66%
2024 -C$0.79 Billion-52.95%
2023 -C$1.67 Billion-32.52%
2022 -C$2.48 Billion24.39%
2021 -C$1.99 Billion-13.21%
2020 -C$2.3 Billion72.69%
2019 -C$1.33 Billion36.01%
2018 -C$0.98 Billion616.83%
2017 -C$0.14 Billion-15.24%
2016 -C$0.17 Billion107.91%
2015 -C$77.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.11 Million-109.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.23 Billion-187.30%๐Ÿ‡บ๐Ÿ‡ธ USA